|
|
Develops therapeutics for rare diseasesUltragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.
Number of employees : 520 people.
|
|
|
| 2016 | 2017 | Delta | | USD (in Million) | % | USD (in Million) | % | | Rare Diseases Treatment Products | 0.133 | 100% | - | - | - | | Collaboration and License | - | - | 2.14 | 81.8% | - | | Product | - | - | 0.476 | 18.2% | - |
|
|
|
| 2016 | 2017 | Delta | | USD (in Million) | % | USD (in Million) | % | | United States | 0.133 | 100% | 2.61 | 100% | +1863.91% |
|
|
|
| Vote  | Quantity | Float | Company-owned shares | Total Float |
| Share A |
1 |
50,182,357 |
46,929,707 |
93.5% |
0 |
0.0% |
93.5% |
|
|
|
| Name | Equities | % | | Wellington Management Co. LLP | 6,090,143 |
12.1% | | Capital Research & Management Co. (Global Investors) | 5,755,563 |
11.5% | | The Vanguard Group, Inc. | 3,976,375 |
7.92% | | Capital Research & Management Co. (International Investors) | 3,604,764 |
7.18% | | BlackRock Fund Advisors | 3,449,796 |
6.87% | | Fidelity Management & Research Co. | 3,441,112 |
6.86% | | Emil D. Kakkis MD, PhD | 3,010,213 |
6.00% | | T. Rowe Price Associates, Inc. | 2,796,392 |
5.57% | | SSgA Funds Management, Inc. | 1,648,751 |
3.29% | | Columbia Wanger Asset Management LLC | 1,291,107 |
2.57% |
|
| Company contact information |
|
Ultragenyx Pharmaceutical, Inc. 60 Leveroni Court Novato, CA 94949 Phone : +1.415.483.8800 Fax : +1.415.483.8810 Web : http://www.ultragenyx.com |
|
|
Sector Bio Therapeutic Drugs
Connections : Ultragenyx Pharmaceutical |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Global Alliance for TB Drug Development | |
|
American Society of Nephrology |
Everylife Foundation for Rare Diseases |
Blackthorn Therapeutics, Inc. | |
|
Emil Kakkis & Jenny Soriano Living Trust |
Dimension Therapeutics, Inc. |
Washington Biotechnology & Biomedical Association | |
|
American Society of Clinical Oncology |
Biotechnology Innovation Organization |
American Society of Hematology |
The Pacific Northwest Research Institute, Inc. |
© 2018 People , Fundamentals and Ownership
|
|
United Kingdom
France
Deutschland
Schweiz (DE)
Report 
